
|Podcasts|April 9, 2021
Podcast: Visus presbyopia drop gets FDA IND OK
A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application
Advertisement
Rhett Schiffman, MD, MHSA, chief medical officer and head of research and development at Visus Therapeutics, talks with Gretchyn Bailey, NCLC, FAAO, editor in chief of Optometry Timesยฎ about Brimichol, the companyโs presbyopia-correcting eyedrop that recently received FDA acceptance of its investigational new drug (IND) application.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Simplifying the treatment of ocular surface disease
2
Classifying dry eye by root cause: A step toward precision medicine
3
3D-printed contact lenses offer patient-specific fit in 20 minutes
4
Atropine, aspherical lenses enter trial for childhood myopia
5






















